334 related articles for article (PubMed ID: 35508804)
1. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma.
Cao Z; Liu X; Zhang W; Zhang K; Pan L; Zhu M; Qin H; Zou C; Wang W; Zhang C; He Y; Lin W; Zhang Y; Han D; Li M; Gu J
ACS Nano; 2023 Dec; 17(23):23746-23760. PubMed ID: 37991252
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
[TBL] [Abstract][Full Text] [Related]
4. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
Lim SH; Yee GT; Khang D
Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX
J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569
[TBL] [Abstract][Full Text] [Related]
7. Membrane-Decorated Exosomes for Combination Drug Delivery and Improved Glioma Therapy.
Liang S; Xu H; Ye BC
Langmuir; 2022 Jan; 38(1):299-308. PubMed ID: 34936368
[TBL] [Abstract][Full Text] [Related]
8. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
9. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
10. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang SF; Zuo FF; Yin BC; Ye BC
Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
[TBL] [Abstract][Full Text] [Related]
11. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy.
Wang Y; Huo Y; Zhao C; Liu H; Shao Y; Zhu C; An L; Chen X; Chen Z
J Control Release; 2024 Apr; 368():170-183. PubMed ID: 38382811
[TBL] [Abstract][Full Text] [Related]
12. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
14. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
15. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
16. NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma.
Fang X; Gong R; Yang D; Li C; Zhang Y; Wang Y; Nie G; Li M; Peng X; Zhang B
J Am Chem Soc; 2024 Jun; 146(22):15251-15263. PubMed ID: 38780071
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma.
Jiang S; Li W; Yang J; Zhang T; Zhang Y; Xu L; Hu B; Li Z; Gao H; Huang Y; Ruan S
ACS Nano; 2024 Feb; 18(8):6445-6462. PubMed ID: 38358804
[TBL] [Abstract][Full Text] [Related]
18. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
[TBL] [Abstract][Full Text] [Related]
19. Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane-Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors.
Xie B; Zhao H; Ding YF; Wang Z; Gao C; Li S; Zhang K; Ip SW; Yu H; Wang R
Adv Sci (Weinh); 2023 Dec; 10(34):e2304407. PubMed ID: 37850572
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy.
Liu Y; Zheng M; Jiao M; Yan C; Xu S; Du Q; Morsch M; Yin J; Shi B
Biomaterials; 2021 Sep; 276():121036. PubMed ID: 34329919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]